New heart valve offers hope for High-Risk chinese patients
NCT ID NCT03466918
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study looked at how safe and effective the SAPIEN 3 heart valve is for Chinese patients with severe aortic stenosis (a narrowed heart valve) who are too high-risk for open-heart surgery. Fifty-eight patients received the valve through a less invasive procedure called TAVI. The main goal was to see how many patients survived, regardless of cause.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fuwai Hospital, CAMS&PUMC
Beijing, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
WestChina Hospital, Sichuan University
Chengdu, China
-
Zhongshan Hospital Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.